StreetInsider.com After-Hours Movers 03/26
Get Alerts PVH Hot Sheet
Price: $97.30 --0%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.2%
Revenue Growth %: -1.3%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.2%
Revenue Growth %: -1.3%
Join SI Premium – FREE
StreetInsider.com After-Hours Movers:
Phillips-Van Heusen Corporation (NYSE: PVH) 3.8% LOWER; reports Q4 EPS of $0.47, 3 cents better than estimates. Revenues were $557.0 million vs. $530.2 million consensus. For the full year 2007, earnings per share is projected to be $3.00 to $3.06, which represents an increase of 15% to 17% over 2006 non-GAAP earnings per share of $2.62. (Consensus is $3.06) Total revenues for the full year 2007 are expected to be approximately $2.4 billion, or approximately 15% over 2006. (Consensus is $2.27 billion)
CombinatoRx Inc. (CRXX) 3.6% LOWER; Provides Topline Results from Phase 2 RA Study with CRx-139 and Very Low Dose Prednisolone. CRx-102 Confirmed as Superior to Prednisolone Alone and Advances on Plan in RA and OA. CRx-139 Misses Primary Endpoint, Shows Significance on Multiple Other Endpoints, Requires Further Analysis.
Ethan Allen Interiors (NYSE: ETH) 1.2% LOWER; Chairman and CEO, Farooq Kathwari, said: "As has been stated by others in our industry, the economic environment for home furnishings retail remains challenging. In addition, in the prior year quarter ended March 2006, we experienced strong growth with sales increasing 15.5%, making prior year comparisons very challenging. Despite these factors, at this stage, we believe we have the opportunity to generate quarterly earnings per share in the range of $0.53 to $0.56 as compared to $0.59 in the prior year quarter." (Consensus is $0.59)
Phillips-Van Heusen Corporation (NYSE: PVH) 3.8% LOWER; reports Q4 EPS of $0.47, 3 cents better than estimates. Revenues were $557.0 million vs. $530.2 million consensus. For the full year 2007, earnings per share is projected to be $3.00 to $3.06, which represents an increase of 15% to 17% over 2006 non-GAAP earnings per share of $2.62. (Consensus is $3.06) Total revenues for the full year 2007 are expected to be approximately $2.4 billion, or approximately 15% over 2006. (Consensus is $2.27 billion)
CombinatoRx Inc. (CRXX) 3.6% LOWER; Provides Topline Results from Phase 2 RA Study with CRx-139 and Very Low Dose Prednisolone. CRx-102 Confirmed as Superior to Prednisolone Alone and Advances on Plan in RA and OA. CRx-139 Misses Primary Endpoint, Shows Significance on Multiple Other Endpoints, Requires Further Analysis.
Ethan Allen Interiors (NYSE: ETH) 1.2% LOWER; Chairman and CEO, Farooq Kathwari, said: "As has been stated by others in our industry, the economic environment for home furnishings retail remains challenging. In addition, in the prior year quarter ended March 2006, we experienced strong growth with sales increasing 15.5%, making prior year comparisons very challenging. Despite these factors, at this stage, we believe we have the opportunity to generate quarterly earnings per share in the range of $0.53 to $0.56 as compared to $0.59 in the prior year quarter." (Consensus is $0.59)
You May Also Be Interested In
- After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
- Vistra plunges 13.5% as Texas election rattles AI power trade, KeyBanc downgrades
- China pledges to reduce trade tensions with Canada
Create E-mail Alert Related Categories
General News, Special ReportsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share